WEDNESDAY 5.27.26 – NASDAQ, Dow, S&P 500 finish at new record highs; notable stocks vary; Oil falls on U.S.-Iran peace deal reports, Straight of Hormuz goals; 10-Year Treasury Yield falls, Gold falls, Dollar Index rises

Artist's Rendition of Stock Market Chart with Line Graph and Numbers adapted from uscc.gov image

The Dow (up 0.4%), NASDAQ (up 1.0%) and S&P 500 (up less than 0.1%) all finished at new record highs on Wednesday, May 27, 2026.

Oil fell after reports that Iran’s state broadcaster said a U.S.-Iranian draft peace deal calls for Strait of Hormuz shipping to return to prewar levels within one month. Front-month contracts of global benchmark Brent crude fell 5.3% to $94.29 per barrel. U.S. crude benchmark West Texas Intermediate futures fell 4.8% to $89.40 per barrel at 4 p.m. ET.


The 10-year Treasury yield, impacting interest mortgage and consumer loan rates, fell to 4.48% from yesterday’s close above 4.49%. Gold futures declined 1.1% to $4,455 per ounce. The U.S. dollar index rose to 99.19 against a basket of foreign trading partner currencies.

After Micron (MU) rose 19% on Tuesday when it topped $1 trillion in market capitalization for the first time, Micron shares rose another 3% on Wednesday. But chip stocks were more varied overall. Qualcomm (QCOM) fell more than 6%. So-called “AI” chip designer Marvell Technology (MRVL) fell 4.6% while awaiting the announcement of its quarterly results after the closing bell. The iShares Semiconductor ETF (SOXX) slipped more than 1%.

Salesforce (CRM) shares have lost a third of their value since the start of 2026 as software stocks have been impacted by concerns about disruption by so-called “AI.” On Wednesday, Salesforce fell less than 1%, also waiting to announce earnings after markets close.

Shares of Cybersecurity company Zscaler (ZS) plunged 32% after Zscaler released a cautious outlook. Bath & Body Works (BBWI) rose nearly 10% after issuing profit guidance stronger than expected. Diabetes management firm Insulet (PODD) dropped 5% after “a voluntary Medical Device Correction” for specific lots of certain insulin pods relating to a manufacturing issue.


Leave a Reply

Your email address will not be published. Required fields are marked *